healthŌme and GalenusRx Forge Strategic Partnership to Launch Genomics-based Personalized Medication Safety Program

News & Events

Keep up with the GalenusRx team

Latest News

June 13, 2024

The NIH estimates that roughly 275,000 cancer patients in the U.S. receive 5-FU, or chemotherapy drug 5-fluorouracil, annually. Up to 3% of those patients experience a toxic reaction. If your oncologist recommends 5-FU as a cancer treatment, you’ll likely have a lot of questions. “Does this treatment make the most

June 3, 2024

Hospitalogy’s May 2024 newsletter highlights Galenus Rx in its Innovative Startup section. Galenus Rx addresses the significant issue of unoptimized medication regimens, which cost billions in preventable adverse drug events and excess morbidity. Their platform, APPRAISE, offers advanced medication safety assessments, analyzing drug interactions down to the DNA level to

May 28, 2024
How did we get here, and what does it mean for the future of pharmacy practice?
March 20, 2024
Partnership Aims to Reduce Adverse Drug Events by Combining Pharmacogenomic Testing and Precision Medication Consultation to Provide Personalized Medication Support Plans for healthŌme Policyholders.
March 14, 2024
Supporting Improved Quality and Outcomes for Healthcare Division Clients

Event Calendar

October 2024
No event found!
Load More